Table 2.
Healthcare resources used for the identification of first CKD diagnosis.
| Healthcare resources | CKD patients |
|---|---|
| N = 1,989 (%) | |
| CKD-related hospital discharge diagnoses* | 1,151 (57.9) |
| Primary diagnosis | 258 (13.0) |
| Secondary diagnosis | 867 (43.6) |
| Procedures | 39 (2.0) |
| CKD-related conditions as indication of use for drug prescriptions | 838 (42.1) |
| Allopurinol | 213 (10.7) |
| Furosemide | 94 (4.7) |
| Polystyrene sulfonate | 63 (3.2) |
| Calcitriol | 56 (2.8) |
| Ramipril | 29 (1.5) |
| Metformin and sulfonamides | 28 (1.4) |
| Acetylsalicylic acid | 24 (1.2) |
| Metformin | 22 (1.1) |
| Electrolytes solutions | 19 (1.0) |
| Glimepiride | 16 (0.8) |
| Ferrous sulfate | 12 (0.6) |
| Torasemide | 12 (0.6) |
| Amlodipine | 11 (0.6) |
| Simvastatin | 10 (0.5) |
| Bisoprolol | 9 (0.5) |
| Nebivolol | 9 (0.5) |
| Losartan | 9 (0.5) |
| Atorvastatin | 9 (0.5) |
| Spironolactone | 8 (0.4) |
| Ramipril plus diuretics | 8 (0.4) |
| Others** | 177 (33.2) |
*Categories of discharge diagnoses and procedures are not mutually exclusive as in some patients CKD-related discharge diagnosis and procedures may have been registered at the same time.
**Other drugs which account for less than 0.4% of first CKD diagnosis identification.